000952.SZ
广济药业
SZSE · Healthcare · C 制造业 · CN
CNY 6.32
−0.94%Margins
Gross margin
25.0%
EBITDA margin
-44.2%
EBIT margin
-68.6%
Net margin
-62.6%
FCF margin
9.9%
-64.1%
Return on equity
-17.4%
Return on assets
-32.9%
Return on invested capital
0.28x
Asset turnover
CNY 93.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026